Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 62559-490

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 62559-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atrop-structure.jpg (Atrop Structure)

Chemical structure diagram of Diphenoxylate Hydrochloride, showing its molecular configuration with specific functional groups and chemical bonds along with associated sulfate and water molecules.*

FDA Label Image

Diphen-structure.jpg (Diphen Structure)

Chemical structure of Diphenoxylate Hydrochloride and Atropine Sulfate showing its molecular composition, including aromatic rings, nitrogen atoms, and ethyl ester groups with a hydrochloride salt component.*

FDA Label Image

Ani.jpg (Ani)

FDA Label Image

Image 01

Label for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets USP, 2.5 mg/0.025 mg, oral tablets in a 100-count package. The label includes dosage details, a caution warning about habit formation, pharmacist dispensing instructions, storage conditions, and manufacturer information for ANI Pharmaceuticals, Inc. It also features the NDC 62559-490-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.